New vaccine aims to train immune system against HPV cancers

NCT ID NCT06319963

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new vaccine called Lenti-HPV-07 in 72 people with HPV-related throat or cervical cancer. The goal is to see if it is safe and can boost the immune system to fight the cancer. Participants receive the vaccine and are monitored for up to one year.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HPV POSITIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Head and Neck Neoplasms human papillomavirus-related squamous cell carcinoma oropharynx cancer oropharynx squamous cell carcinoma Uterine Cervical Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Florida Cancer Specialists (from Sarah Canon research Institute)

    RECRUITING

    Orlando, Florida, 32827, United States

    Contact

  • Moffitt Cancer Center

    RECRUITING

    Tampa, Florida, 33612, United States

    Contact

  • Oklahoma Cancer Specialists and Research Institute, LLC

    RECRUITING

    Tulsa, Oklahoma, 74146, United States

    Contact

  • Tampa General Hospital

    RECRUITING

    Tampa, Florida, 33606, United States

    Contact